VPAResearch: Market Research Reports

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Myocardial Ischemia pipeline product. ... provides key trends in Myocardial Ischemia pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... estimated 0.2 billion population is affected worldwide and the market size of Peripheral Arterial Disease (PAD) is estimated to be around $4.5 billion. To assist researchers, ... has come up with a comprehensive report on Peripheral Arterial Disease (PAD) pipeline. The report provides insights into different ...

... estimated 0.2 billion population is affected worldwide and the market size of Peripheral Vascular Disease (PVD) is estimated to be around $4.5 billion. To assist researchers, ... has come up with a comprehensive report on Peripheral Vascular Disease (PVD) pipeline. The report provides insights into different ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Pulmonary Embolism pipeline product. ... provides key trends in Pulmonary Embolism pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Raynauds Disease pipeline product. Mechanism of Action ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Raynaud's Phenomenon pipeline product. Mechanism of Action ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Raynaud's Syndrome pipeline product. Mechanism of Action ...

... entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Reoxygenation Injury pipeline product. ... provides key trends in Reoxygenation Injury pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Restenosis pipeline product. Mechanism of Action and ...

... and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Septic Shock pipeline product. Mechanism ... provides key trends in Septic Shock pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... Research has come up with a comprehensive report on Sickle Cell Disease Or Sickle Cell Anemia pipeline. The report provides insights into different therapeutic ... each product, the report provides key trends in Sickle Cell Disease Or Sickle Cell Anemia pipeline studies. The products under development are ...

... companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Thromboembolism pipeline product. Mechanism of Action and ...

... entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Vaso-Occlusive Crisis pipeline product. ... key trends in Vaso-Occlusive Crisis pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Ventricular Tachycardia pipeline product. ... key trends in Ventricular Tachycardia pipeline studies. The products under development are categorized according to their development phase, mechanism and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Constipation pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Diabetic gastroparesis pipeline product. Mechanism of Action ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Diarrhea pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Dyspepsia pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Enterocolitis pipeline product. Mechanism of Action and ...

... 15 companies and universities are focusing on developing treatment options for Eosinophilic Esophagitis. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Eosinophilic Esophagitis pipeline product. ...

... universities are focusing on developing treatment options for Exocrine Pancreatic Insufficiency. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Exocrine Pancreatic Insufficiency pipeline product. ...

Gastritis is the inflammation of mucosa, lining of stomach, that can last for shorter periods or longer durations. Infection, alcohol and intake of NSAIDs lead to gastritis. ... /IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other ...

... Gastroesophageal Reflux Disease (GERD). To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Gastroesophageal Reflux Disease (GERD ... the report provides key trends in Gastroesophageal Reflux Disease (GERD) pipeline studies. The products under ...

... billion market in the US alone, Hepatic Encephalopathy is a GI disorder affecting around 2 million people in the country. Hepatic Encephalopathy (HE) is a neuropsychiatric syndrome with ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatic Encephaopathy ...

... 30 companies and universities are focusing on developing treatment options for Liver Failure (Hepatic Insufficiency). To assist investigators and funding and ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Failure (Hepatic Insufficiency) pipeline product ...

... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Irritable Bowel Syndrome pipeline product. Mechanism of Action ...

... Over 20 companies and universities are focusing on developing treatment options for Liver Cirrhosis. To assist investigators and funding and regulatory organizations ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Cirrhosis pipeline product. ...

... Over 30 companies and universities are focusing on developing treatment options for Liver Failure (Hepatic Insufficiency). To assist investigators and funding ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Failure (Hepatic Insufficiency) ...

... Opioid Induced Constipation (OIC). To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Opioid Induced Constipation (OIC ... , the report provides key trends in Opioid Induced Constipation (OIC) pipeline studies. The products under development ...

... Over 30 companies and universities are focusing on developing treatment options for Oral Mucositis. To assist investigators and funding and regulatory organizations ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Oral Mucositis pipeline product. ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Pancreatitis pipeline product. Mechanism of Action and ...

... Over 20 companies and universities are focusing on developing treatment options for Peptic Ulcers. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Peptic Ulcers pipeline product. Mechanism ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Peritonitis pipeline product. Mechanism of Action and ...

... companies and universities are focusing on developing treatment options for Post Operative Nausea and Vomiting. To assist investigators and funding and regulatory ... , VPA Research has come up with a comprehensive report on Post Operative Nausea and Vomiting pipeline. The report provides insights into different ...

... and universities are focusing on developing treatment options for Primary biliary cirrhosis. To assist investigators and funding and regulatory organizations, ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary biliary cirrhosis pipeline product. Mechanism ...

... universities are focusing on developing treatment options for Primary billary cholangitis. To assist investigators and funding and regulatory organizations ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary billary cholangitis pipeline product. Mechanism ...

... universities are focusing on developing treatment options for Primary sclerosing cholangitis. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Primary sclerosing cholangitis pipeline product. Mechanism ...

... Around 30 companies and universities are focusing on developing treatment options for Reflux Esophagitis/GERD. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Reflux Esophagitis/GERD pipeline product. ...

... and universities are focusing on developing treatment options for Short Bowel Syndrome. To assist investigators and funding and regulatory organizations, ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Short Bowel Syndrome pipeline product. Mechanism of ...

... Around 15 companies and universities are focusing on developing treatment options for Systemic Mastocytosis. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Systemic Mastocytosis pipeline product. ...

... Around 10 companies and universities are focusing on developing treatment options for Traveler's Diarrhea. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Traveler's Diarrhea pipeline product. ...

... and universities are focusing on developing treatment options for Alcoholic Hepatitis. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Alcoholic Hepatitis pipeline product. ...

... and universities are focusing on developing treatment options for Atrial Fibrillation. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Atrial Fibrillation pipeline product. ...

... , neurological conditions. Celiac Disease pipeline comprises of 24 active drugs under active development as of April 2018. Of these, 4 drugs are in Phase 1 and 4 drugs in phase 2. None of the drugs have progressed ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Colitis pipeline product. Mechanism of Action and ...

... myalgia, arthralgia are key symptoms. Community Acquired Pneumonia pipeline comprises of 16 drugs under active development as of April 2018. Of these, 3 drugs are ... has come up with a comprehensive report on Community Acquired Pneumonia (CAP) pipeline. The report provides insights into different therapeutic ...

... Critical Limb Ischemia worldwide, with an estimated market size of $10 to $12 billion. Critical Limb Ischemia pipeline comprises of 27 active drugs under active development as of April 2018 ... come up with a comprehensive report on Critical Limb Ischemia (CLI) pipeline. The report provides insights into ...

... no vaccine is available against HCV. Due to the mutations in Hepatitis C virus, development of a prophylactic vaccine is highly challenging. The condition is classified ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatitis C (HCV) pipeline ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Pre-eclampsia pipeline product. Mechanism of Action and ...

... scalp are affected areas. Trigeminal Neuralgia pipeline comprises of 9 active drugs under active development as of April 2018. Of these, 4 drugs are in phase 2. Further, 4 drugs are in Pre-clinical stage ...